Novartis’ Hinshaw Joins Axcella Health as President & CEO

Xconomy Boston — 

Axcella Health has appointed William Hinshaw to serve as president and CEO. Before joining the Cambridge, MA, biotech company, Hinshaw was executive vice president and head of U.S. oncology for Novartis (NYSE: NVS). Axcella is developing protein drugs to address metabolic dysregulation. The company’s drug pipeline includes compounds for muscle, liver, and central nervous system disorders.